Angle.
48 announcements.
48 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 29-10-2025 | AGL | Angle | CHANGE OF NAME |
| 07:00 | 16-10-2025 | AGL | Angle | Appointments: Interim CEO and senior board advisor |
| 07:00 | 08-10-2025 | AGL | Angle | Strategy Update |
| 07:00 | 29-09-2025 | AGL | Angle | Presentation of Data on Glioblastoma |
| 07:00 | 12-09-2025 | AGL | Angle | Board Changes |
| 07:00 | 09-09-2025 | AGL | Angle | Change of Adviser |
| 07:01 | 09-09-2025 | AGL | Angle | Interim Results |
| 14:58 | 05-09-2025 | AGL | Angle | Notice of Results |
| 07:00 | 20-08-2025 | AGL | Angle | ANGLE announces collaboration with Myriad Genetics |
| 07:00 | 08-07-2025 | AGL | Angle | PARSORTIX ENABLES STUDY OF CANCER PROGRESSION |
| 17:50 | 30-06-2025 | AGL | Angle | Result of 2025 Annual General Meeting |
| 07:00 | 17-06-2025 | AGL | Angle | EACR 2025: Innovation in AR expression profiling |
| 07:00 | 17-06-2025 | AGL | Angle | EACR 2025: Data demonstrating DNA dual analysis |
| 07:00 | 10-06-2025 | AGL | Angle | Novel discoveries into the biology of cancer |
| 07:00 | 09-06-2025 | AGL | Angle | POSTING OF ANNUAL REPORT AND NOTICE OF AGM |
| 07:00 | 06-06-2025 | AGL | Angle | Board Changes |
| 07:00 | 28-05-2025 | AGL | Angle | Preliminary Results |
| 07:00 | 23-05-2025 | AGL | Angle | Notice of Results |
| 07:00 | 28-04-2025 | AGL | Angle | RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME |
| 07:00 | 21-03-2025 | AGL | Angle | Issue of LTIP Options and Share Options |
| 07:00 | 21-03-2025 | AGL | Angle | Results of Eisai Phase 2 pilot study |
| 07:00 | 06-02-2025 | AGL | Angle | Novel findings using Parsortix |
| 07:00 | 29-01-2025 | AGL | Angle | Analysis of CTC-DNA and ctDNA using Illumina assay |
| 10:05 | 24-01-2025 | AGL | Angle | Parsortix used in research paper from ETH Zurich |
| 07:00 | 23-01-2025 | AGL | Angle | Trading Update |
| 08:43 | 13-12-2024 | AGL | Angle | HER2 presentation at SABCS |
| 07:00 | 26-09-2024 | AGL | Angle | Half-year Report |
| 07:00 | 23-09-2024 | AGL | Angle | Exclusive agreement for DNA NGS panel |
| 07:00 | 17-09-2024 | AGL | Angle | Notice of Interim Results and Webcast |
| 15:07 | 11-07-2024 | AGL | Angle | Result of 2024 Annual General Meeting |
| 07:00 | 21-06-2024 | AGL | Angle | Result of open offer |
| 14:41 | 18-06-2024 | AGL | Angle | Posting of 2023 Annual Report & Notice of the AGM |
| 16:37 | 06-06-2024 | AGL | Angle | Publication of Circular |
| 16:04 | 05-06-2024 | AGL | Angle | Results of placing and subscription |
| 07:00 | 05-06-2024 | AGL | Angle | Proposed Placing, Subscription and Open Offer |
| 07:00 | 05-06-2024 | AGL | Angle | Preliminary Results |
| 07:00 | 03-05-2024 | AGL | Angle | New commercial agreement with large pharma |
| 07:00 | 24-04-2024 | AGL | Angle | New commercial agreement with AstraZeneca |
| 07:00 | 22-04-2024 | AGL | Angle | US and EU patents for innovative CellKeep™ slide |
| 07:00 | 04-01-2024 | AGL | Angle | Breakthrough clinical results |
| 07:00 | 02-01-2024 | AGL | Angle | Contract announcement with Eisai Inc. |
| 07:00 | 11-12-2023 | AGL | Angle | Broker Announcement |
| 07:00 | 09-11-2023 | AGL | Angle | Trading and business update |
| 07:00 | 07-09-2023 | AGL | Angle | Interim Results for the period ended 30 June 2023 |
| 07:00 | 15-08-2023 | AGL | Angle | ANGLE notice of interim results |
| 16:54 | 28-06-2023 | AGL | Angle | Result of 2023 Annual General Meeting |
| 07:00 | 25-05-2023 | AGL | Angle | Pharma services contract with Artios Pharma |
| 07:00 | 22-05-2023 | AGL | Angle | Board change - appointment of new Chairman |